Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$164.16 USD
-0.66 (-0.40%)
Updated Sep 20, 2024 04:00 PM ET
After-Market: $163.98 -0.18 (-0.11%) 7:58 PM ET
4-Sell of 5 4
C Value F Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
10/15/2024
Time: BMO |
9/2024 | $2.19 | -7.82% |
Earnings Summary
For their last quarter, Johnson & Johnson (JNJ) reported earnings of $2.82 per share, beating the Zacks Consensus Estimate of $2.71 per share. This reflects a positive earnings surprise of 4.06%. Look out for JNJ's next earnings release on October 15, 2024. For the next earning release, we expect the company to report earnings of $2.19 per share, reflecting a year-over-year decrease of 17.67%.
Earnings History
Price & Consensus
Zacks News for JNJ
J&J's Rybrevant Receives FDA Nod for Expanded Use in NSCLC
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services